Vaso (VASO) Stock Price
Vaso Price
Over the last 19 years Vaso grew revenue by 9.6% annually, reaching 86.77 M USD. Earnings per share have declined at 2.9% per year over the last 10 years. For Vaso, the net margin of 1.1% is broadly stable versus 0.5% a few years ago. The stock trades about 127% above its 52-week low.
Vaso stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Vaso over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Vaso stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Vaso's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Vaso Price |
|---|---|
| 8/6/2026 | 0.25 USD |
| 8/5/2026 | 0.25 USD |
| 8/4/2026 | 0.25 USD |
| 8/3/2026 | 0.26 USD |
| 7/31/2026 | 0.19 USD |
| 7/30/2026 | 0.19 USD |
| 7/29/2026 | 0.20 USD |
| 7/27/2026 | 0.20 USD |
| 7/23/2026 | 0.19 USD |
| 7/22/2026 | 0.20 USD |
| 7/21/2026 | 0.19 USD |
| 7/20/2026 | 0.19 USD |
| 7/17/2026 | 0.20 USD |
| 7/16/2026 | 0.20 USD |
| 7/15/2026 | 0.20 USD |
| 7/14/2026 | 0.20 USD |
| 7/13/2026 | 0.19 USD |
| 7/10/2026 | 0.20 USD |
| 7/9/2026 | 0.19 USD |
| 7/8/2026 | 0.19 USD |
| 7/7/2026 | 0.19 USD |
| 7/6/2026 | 0.19 USD |
| 7/2/2026 | 0.19 USD |
| 7/1/2026 | 0.18 USD |
| 6/30/2026 | 0.19 USD |
| 6/29/2026 | 0.18 USD |
| 6/26/2026 | 0.19 USD |
| 6/25/2026 | 0.19 USD |
| 6/24/2026 | 0.20 USD |
| 6/23/2026 | 0.19 USD |
| 6/22/2026 | 0.18 USD |
| 6/18/2026 | 0.18 USD |
| 6/17/2026 | 0.18 USD |
| 6/16/2026 | 0.19 USD |
| 6/15/2026 | 0.19 USD |
| 6/12/2026 | 0.19 USD |
| 6/11/2026 | 0.19 USD |
| 6/10/2026 | 0.19 USD |
| 6/9/2026 | 0.19 USD |
| 6/8/2026 | 0.19 USD |
| 6/5/2026 | 0.20 USD |
| 6/4/2026 | 0.19 USD |
| 6/3/2026 | 0.20 USD |
| 6/2/2026 | 0.20 USD |
| 6/1/2026 | 0.22 USD |
| 5/29/2026 | 0.21 USD |
| 5/28/2026 | 0.21 USD |
| 5/27/2026 | 0.22 USD |
| 5/26/2026 | 0.23 USD |
| 5/22/2026 | 0.23 USD |
| 5/21/2026 | 0.21 USD |
| 5/20/2026 | 0.23 USD |
| 5/19/2026 | 0.23 USD |
| 5/18/2026 | 0.25 USD |
| 5/15/2026 | 0.23 USD |
| 5/14/2026 | 0.19 USD |
| 5/13/2026 | 0.19 USD |
| 5/12/2026 | 0.20 USD |
| 5/11/2026 | 0.20 USD |
| 5/8/2026 | 0.18 USD |
| 5/7/2026 | 0.18 USD |
| 5/6/2026 | 0.19 USD |
| 5/5/2026 | 0.19 USD |
| 5/4/2026 | 0.18 USD |
| 5/1/2026 | 0.19 USD |
| 4/30/2026 | 0.18 USD |
| 4/29/2026 | 0.18 USD |
| 4/28/2026 | 0.18 USD |
| 4/27/2026 | 0.18 USD |
| 4/24/2026 | 0.18 USD |
| 4/23/2026 | 0.19 USD |
| 4/22/2026 | 0.19 USD |
| 4/21/2026 | 0.19 USD |
| 4/20/2026 | 0.19 USD |
| 4/17/2026 | 0.18 USD |
| 4/16/2026 | 0.17 USD |
| 4/15/2026 | 0.17 USD |
| 4/14/2026 | 0.16 USD |
| 4/13/2026 | 0.16 USD |
| 4/10/2026 | 0.16 USD |
| 4/9/2026 | 0.16 USD |
| 4/8/2026 | 0.16 USD |
| 4/7/2026 | 0.16 USD |
| 4/6/2026 | 0.16 USD |
| 4/2/2026 | 0.16 USD |
| 4/1/2026 | 0.17 USD |
| 3/31/2026 | 0.17 USD |
| 3/30/2026 | 0.17 USD |
| 3/27/2026 | 0.17 USD |
| 3/26/2026 | 0.18 USD |
| 3/25/2026 | 0.18 USD |
| 3/24/2026 | 0.18 USD |
| 3/23/2026 | 0.18 USD |
| 3/20/2026 | 0.17 USD |
| 3/19/2026 | 0.17 USD |
| 3/18/2026 | 0.17 USD |
| 3/17/2026 | 0.17 USD |
| 3/16/2026 | 0.17 USD |
| 3/13/2026 | 0.17 USD |
| 3/12/2026 | 0.17 USD |
| 3/11/2026 | 0.17 USD |
| 3/10/2026 | 0.17 USD |
| 3/9/2026 | 0.17 USD |
| 3/6/2026 | 0.17 USD |
| 3/5/2026 | 0.17 USD |
| 3/4/2026 | 0.17 USD |
| 3/3/2026 | 0.18 USD |
| 3/2/2026 | 0.18 USD |
| 2/27/2026 | 0.18 USD |
| 2/26/2026 | 0.18 USD |
| 2/25/2026 | 0.18 USD |
| 2/24/2026 | 0.18 USD |
| 2/23/2026 | 0.17 USD |
| 2/20/2026 | 0.18 USD |
| 2/19/2026 | 0.18 USD |
| 2/18/2026 | 0.18 USD |
| 2/17/2026 | 0.17 USD |
| 2/13/2026 | 0.18 USD |
| 2/12/2026 | 0.18 USD |
| 2/11/2026 | 0.18 USD |
| 2/10/2026 | 0.18 USD |
| 2/9/2026 | 0.18 USD |
| 2/6/2026 | 0.19 USD |
| 2/5/2026 | 0.19 USD |
| 2/4/2026 | 0.19 USD |
| 2/3/2026 | 0.19 USD |
| 2/2/2026 | 0.19 USD |
| 1/30/2026 | 0.18 USD |
| 1/29/2026 | 0.18 USD |
| 1/28/2026 | 0.17 USD |
| 1/27/2026 | 0.17 USD |
| 1/26/2026 | 0.17 USD |
| 1/23/2026 | 0.18 USD |
| 1/22/2026 | 0.17 USD |
| 1/21/2026 | 0.17 USD |
| 1/20/2026 | 0.17 USD |
| 1/16/2026 | 0.17 USD |
| 1/15/2026 | 0.17 USD |
| 1/14/2026 | 0.17 USD |
| 1/13/2026 | 0.17 USD |
| 1/12/2026 | 0.18 USD |
| 1/9/2026 | 0.18 USD |
| 1/8/2026 | 0.17 USD |
| 1/7/2026 | 0.17 USD |
| 1/6/2026 | 0.17 USD |
| 1/5/2026 | 0.17 USD |
| 1/2/2026 | 0.17 USD |
| 12/31/2025 | 0.17 USD |
| 12/30/2025 | 0.18 USD |
| 12/29/2025 | 0.18 USD |
| 12/26/2025 | 0.17 USD |
| 12/24/2025 | 0.17 USD |
| 12/23/2025 | 0.17 USD |
| 12/22/2025 | 0.17 USD |
| 12/19/2025 | 0.17 USD |
| 12/18/2025 | 0.17 USD |
| 12/17/2025 | 0.17 USD |
| 12/16/2025 | 0.17 USD |
| 12/15/2025 | 0.17 USD |
| 12/12/2025 | 0.17 USD |
| 12/11/2025 | 0.17 USD |
| 12/10/2025 | 0.17 USD |
| 12/9/2025 | 0.17 USD |
| 12/8/2025 | 0.17 USD |
| 12/5/2025 | 0.17 USD |
| 12/4/2025 | 0.16 USD |
| 12/3/2025 | 0.16 USD |
| 12/2/2025 | 0.16 USD |
| 12/1/2025 | 0.16 USD |
| 11/28/2025 | 0.16 USD |
| 11/26/2025 | 0.16 USD |
| 11/25/2025 | 0.15 USD |
| 11/24/2025 | 0.15 USD |
| 11/21/2025 | 0.14 USD |
| 11/20/2025 | 0.14 USD |
| 11/19/2025 | 0.17 USD |
| 11/18/2025 | 0.14 USD |
| 11/17/2025 | 0.14 USD |
| 11/14/2025 | 0.12 USD |
| 11/13/2025 | 0.11 USD |
| 11/12/2025 | 0.11 USD |
| 11/11/2025 | 0.11 USD |
| 11/10/2025 | 0.11 USD |
| 11/7/2025 | 0.11 USD |
| 11/6/2025 | 0.12 USD |
| 11/5/2025 | 0.12 USD |
| 11/4/2025 | 0.12 USD |
| 11/3/2025 | 0.11 USD |
| 10/31/2025 | 0.11 USD |
| 10/30/2025 | 0.11 USD |
| 10/29/2025 | 0.11 USD |
| 10/28/2025 | 0.11 USD |
| 10/27/2025 | 0.11 USD |
| 10/24/2025 | 0.12 USD |
| 10/23/2025 | 0.11 USD |
| 10/22/2025 | 0.11 USD |
| 10/21/2025 | 0.12 USD |
| 10/20/2025 | 0.12 USD |
| 10/17/2025 | 0.12 USD |
| 10/16/2025 | 0.12 USD |
| 10/15/2025 | 0.12 USD |
| 10/14/2025 | 0.12 USD |
| 10/13/2025 | 0.12 USD |
| 10/10/2025 | 0.12 USD |
| 10/9/2025 | 0.12 USD |
| 10/8/2025 | 0.12 USD |
| 10/7/2025 | 0.12 USD |
| 10/6/2025 | 0.12 USD |
| 10/3/2025 | 0.12 USD |
| 10/2/2025 | 0.12 USD |
| 10/1/2025 | 0.12 USD |
| 9/30/2025 | 0.12 USD |
| 9/29/2025 | 0.12 USD |
| 9/26/2025 | 0.12 USD |
| 9/25/2025 | 0.12 USD |
| 9/24/2025 | 0.11 USD |
| 9/23/2025 | 0.12 USD |
| 9/22/2025 | 0.12 USD |
| 9/19/2025 | 0.12 USD |
| 9/18/2025 | 0.12 USD |
| 9/17/2025 | 0.12 USD |
| 9/16/2025 | 0.12 USD |
| 9/15/2025 | 0.13 USD |
| 9/12/2025 | 0.12 USD |
| 9/11/2025 | 0.12 USD |
| 9/10/2025 | 0.12 USD |
| 9/9/2025 | 0.12 USD |
| 9/8/2025 | 0.13 USD |
| 9/5/2025 | 0.12 USD |
| 9/4/2025 | 0.13 USD |
| 9/3/2025 | 0.13 USD |
| 9/2/2025 | 0.13 USD |
| 8/29/2025 | 0.13 USD |
| 8/28/2025 | 0.12 USD |
| 8/27/2025 | 0.13 USD |
| 8/26/2025 | 0.12 USD |
| 8/25/2025 | 0.12 USD |
| 8/22/2025 | 0.12 USD |
| 8/21/2025 | 0.12 USD |
| 8/20/2025 | 0.11 USD |
| 8/19/2025 | 0.12 USD |
| 8/18/2025 | 0.13 USD |
| 8/15/2025 | 0.13 USD |
| 8/14/2025 | 0.12 USD |
| 8/13/2025 | 0.12 USD |
| 8/12/2025 | 0.13 USD |
| 8/11/2025 | 0.12 USD |
Vaso Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Vaso Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.00 | 4.00 | 16.00 | 29.00 | 32.00 | 34.00 | 57.00 | 72.00 | 72.00 | 73.00 | 75.00 | 69.00 | 75.00 | 80.00 | 81.00 | 86.00 |
| -20.00 | – | 300.00 | 81.25 | 10.34 | 6.25 | 67.65 | 26.32 | – | 1.39 | 2.74 | -8.00 | 8.70 | 6.67 | 1.25 | 6.17 |
| 25.00 | 50.00 | 62.50 | 68.97 | 68.75 | 73.53 | 61.40 | 56.94 | 55.56 | 56.16 | 56.00 | 55.07 | 57.33 | 60.00 | 61.73 | 60.47 |
| 1.00 | 2.00 | 10.00 | 20.00 | 22.00 | 25.00 | 35.00 | 41.00 | 40.00 | 41.00 | 42.00 | 38.00 | 43.00 | 48.00 | 50.00 | 52.00 |
| -1.00 | -1.00 | -3.00 | -3.00 | -1.00 | 1.00 | 3.00 | 1.00 | -3.00 | -3.00 | – | – | 2.00 | 7.00 | 4.00 | 2.00 |
| -25.00 | -25.00 | -18.75 | -10.34 | -3.13 | 2.94 | 5.26 | 1.39 | -4.17 | -4.11 | – | – | 2.67 | 8.75 | 4.94 | 2.33 |
| -1.00 | -1.00 | -4.00 | -3.00 | -1.00 | 1.00 | 3.00 | – | -4.00 | -3.00 | – | – | 6.00 | 11.00 | 4.00 | – |
| – | – | 300.00 | -25.00 | -66.67 | -200.00 | 200.00 | – | – | -25.00 | – | – | – | 83.33 | -63.64 | – |
| 99.56 | 101.78 | 111.98 | 158.37 | 159.38 | 156.03 | 157.19 | 159.40 | 162.21 | 165.42 | 167.84 | 170.85 | 173.77 | 174.66 | 175.54 | 175.59 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Vaso generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Vaso retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Vaso's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Vaso has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Vaso's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Vaso stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Vaso Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Vaso business model & stock analysis
Vaso SWOT Analysis
Strengths
Vaso Corp has several key strengths that contribute to its success:
- Strong market position: Vaso Corp holds a significant market share in the healthcare industry, ensuring its brand recognition and stability.
- Diverse product portfolio: The company offers a wide range of innovative medical devices and equipment, catering to various medical specialties.
- Established distribution network: Vaso Corp has an extensive distribution network, enabling efficient delivery of products to healthcare facilities worldwide.
- Financial stability: The company has maintained solid financial performance, with consistent revenue growth and profitability.
Weaknesses
Despite its strengths, Vaso Corp also faces certain weaknesses:
- Limited geographic presence: The company's operations are primarily concentrated in specific regions, which limits its ability to fully tap into global markets.
- Dependence on key clients: Vaso Corp heavily relies on a few major clients for a significant portion of its revenue, making it vulnerable to fluctuations in their demand or financial stability.
- Technological dependence: The industry is rapidly evolving, and Vaso Corp must continuously invest in research and development to stay ahead, which poses financial and resource challenges.
Opportunities
Vaso Corp can capitalize on the following opportunities:
- Emerging markets: Expansion into developing healthcare markets presents potential for Vaso Corp to reach new customer segments and increase market share.
- Advancements in healthcare technology: The growing demand for innovative medical devices provides an opportunity for Vaso Corp to introduce new products and gain a competitive edge.
- Strategic partnerships: Collaborating with other healthcare companies or institutions can enable Vaso Corp to access new markets, technologies, and expertise.
Threats
Vaso Corp should be mindful of the following threats:
- Intense competition: The healthcare industry is highly competitive, with numerous established players and new entrants, potentially impacting Vaso Corp's market share and margins.
- Regulatory challenges: Compliance with stringent healthcare regulations imposes additional costs and may require modifications to products, impacting Vaso Corp's profitability.
- Economic downturns: During economic crises or recessions, healthcare spending may decrease, affecting demand for Vaso Corp's products and services.
Vaso Segments
Vaso Revenue by Segment (1/6)
3 Years
5 Years
Max
Details
Vaso Revenue by Segment (2/6)
Max
Details
Vaso Revenue by Segment (3/6)
Max
Details
Vaso Revenue by Segment (4/6)
3 Years
5 Years
Max
Details
Vaso Revenue by Segment (5/6)
3 Years
5 Years
10 Years
Max
Details
Vaso Revenue by Segment (6/6)
3 Years
5 Years
10 Years
Max
Details
Vaso Revenue by Region
3 Years
5 Years
10 Years
Max
Details
Vaso Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Vaso historical P/E ratio, EBIT multiple, and P/S ratio
Vaso annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Vaso shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Vaso stock splits
Vaso shareholder structure
| % | Name |
|---|---|
31.74272% | |
5.97865% | |
1.77967% | |
0.92543% | |
0.91409% | |
0.91074% |
Vaso Executives and Management Board
9 members · avg. age 65 · 11 % women
Dr. Jun Ma (61)
President, Chief Executive Officer, Director · since 2007
756,635.00 USD
Management
Ms. Jane Moen (45)
Chief Operating Officer, Director, President of VasoHealthcare · since 2018
Mr. Jonathan Newton (63)
Chief Financial Officer, Treasurer, Company Secretary
Mr. Peter Castle (56)
President of the VasoTechnology, Inc. · since 2010
Board of Directors
Mr. Joshua Markowitz (69)
Independent Chairman of the Board
Mr. Edgar Rios (72)
Independent Vice Chairman of the Board
Mr. Behnam Movaseghi (71)
Independent Director
Mr. David Lieberman (80)
Director
Mr. Leon Dembo (70)
Independent Director
Frequently asked questions about Vaso
Vaso Corp's business model focuses on providing healthcare solutions and products. As a leading provider of healthcare information technology, Vaso Corp specializes in offering software and services that enhance patient care delivery and optimize clinical outcomes. The company operates through two primary segments: IT solutions and professional services, including equipment sales. Vaso Corp combines innovative technology with their expertise in the healthcare industry to offer comprehensive solutions that improve patient care and streamline healthcare operations. With a mission to empower healthcare organizations, Vaso Corp is dedicated to driving positive change in the healthcare industry through their cutting-edge solutions and services.
Vaso Corp is primarily active in the healthcare industry, specializing in providing medical technology and software solutions. With its focus on healthcare, Vaso Corp offers a wide range of services, including specialized equipment and devices, IT solutions, clinical training, and consulting services for hospitals and medical institutions. Leveraging its expertise in healthcare technology, Vaso Corp aims to improve patient care, enhance clinical outcomes, and optimize operational efficiency for healthcare providers worldwide. With its strong presence in the healthcare sector, Vaso Corp continues to play a vital role in advancing medical technology and improving healthcare delivery.
The main competitors of Vaso Corp in the market include GE Healthcare, Siemens Healthineers, and Philips Healthcare. These industry giants are renowned for their medical imaging and diagnostic solutions, offering similar products and services as Vaso Corp. In a highly competitive market, Vaso Corp aims to differentiate itself by focusing on innovative technologies, efficient delivery, and exceptional customer service. By continually adapting to changing industry trends and customer demands, Vaso Corp strives to maintain its competitive edge.
Vaso Corp is a company with a rich history and background in the medical technology industry. Founded in 1987, Vaso Corp has been a leading provider of healthcare solutions, specializing in offering advanced medical imaging systems and equipment. With a strong focus on innovation, the company has continuously developed and distributed state-of-the-art imaging technologies to hospitals, clinics, and research facilities worldwide. Vaso Corp's commitment to excellence has garnered them a reputation for delivering high-quality, reliable, and cost-effective solutions to healthcare providers. With decades of experience and a passion for improving patient care, Vaso Corp remains at the forefront of the medical technology industry.
Vaso Corp has achieved several significant milestones. The company has successfully established itself as a leading provider of healthcare IT solutions, specializing in the design and implementation of advanced medical imaging technologies. Vaso Corp has expanded its global presence by establishing strategic partnerships and acquiring prominent industry players. The company's commitment to innovation has resulted in the development of cutting-edge medical imaging software, enhancing diagnostic accuracy and improving patient care. Furthermore, Vaso Corp's consistent dedication to customer satisfaction and quality service has earned them a reputable position in the healthcare industry.
Vaso Corp is primarily present in various countries and regions globally. Some of the key markets where Vaso Corp operates include the United States, Europe, Asia Pacific, and Latin America. With a global presence, Vaso Corp strategically serves clients and customers across these regions, leveraging its expertise in the healthcare technology and services industry.
Vaso Corp represents a set of values and corporate philosophy that prioritize excellence, innovation, and customer satisfaction. The company strives to deliver cutting-edge solutions and services in healthcare IT and medical equipment domains. Vaso Corp values integrity and transparency in its operations, fostering strong relationships with clients and partners. With a focus on technological advancement, Vaso Corp continuously seeks to empower healthcare providers and improve patient outcomes through its state-of-the-art solutions. By combining expertise, industry knowledge, and a customer-centric approach, Vaso Corp remains dedicated to delivering value and contributing to the growth and development of the healthcare industry.
Converted at the current exchange rate, the Vaso share trades at 0.22 EUR (0.25 USD).
Vaso Corp is a US-American company that specializes in the development and marketing of medical products and equipment. The company has been focusing on innovative products and state-of-the-art technologies for almost three decades to meet the needs of its customers. The business activities of Vaso Corp can be divided into three main divisions: VasoMedical, VasoTechnology, and VasoHealthcare. Each division focuses on specific products and services that meet the requirements of their respective industries. VasoMedical is the medical device division of Vaso Corp. It offers a wide range of cardiology diagnostic devices and supportive systems. This includes the VasoScan product line with innovative ultrasound Doppler systems, which allow doctors to measure blood flow in the body and detect possible circulatory disorders. VasoTechnology is a division that specializes in IT solutions and services. The product range includes software and hardware solutions as well as infrastructure services. VasoTechnology offers innovative and customized IT solutions that can be used in both the medical and non-medical sectors. VasoHealthcare is the newest division of Vaso Corp. It offers a unique digital health management system that allows doctors and hospitals to optimize the medical care of their patients. Various technologies such as telemedicine, artificial intelligence, or virtual consulting services are used. The system enables seamless information exchange between doctors and patients, thus contributing to the improvement of patient care. In addition to the mentioned divisions, Vaso Corp also offers a variety of products that perfectly meet the customers' requirements. This includes not only the above-mentioned VasoScan products but also pharmaceuticals and medical devices sold in the VasoPharma business unit. The business model of Vaso Corp is based on the notion that innovation and technology play a crucial role in healthcare. The company aims to offer products and services that improve medical care and increase efficiency in the healthcare sector. The company places great emphasis on quality and user-friendliness. Vaso Corp is an innovative company that impresses with its products as well as its services. It is a leading provider of medical devices, IT solutions, and digital health management systems that advance healthcare and improve patient care.
The revenue cannot currently be calculated for Vaso.
The profit cannot currently be calculated for Vaso.
The P/E ratio cannot be calculated for Vaso at the moment.
The P/S cannot be calculated for Vaso currently.
The Eulerpool Quality Score for Vaso is 3/10.
The ISIN of Vaso is US92233F1021. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Vaso is A2DHFY. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Vaso is VASO. The ticker symbol is used to trade Vaso shares on the stock exchange.
Vaso paid dividends every year for the past 0 years.
Vaso is assigned to the 'Health' sector.
The dividends of Vaso are distributed in USD.
Vaso stock
Vaso Peer Group
Vaso Ticker
Vaso FIGI
All fundamentals and in-depth analysis of Vaso
Our stock analysis for Vaso stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vaso. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.